Attachment A Pricing Spreadsheet.xlsx
XLSX spreadsheet 17 KB Posted
- Attached to
- South Texas Radiopharmaceuticals Federal contract opportunity
- Solicitation number
- 36C25723Q0254
About this file
This document contains a pricing spreadsheet for a five-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract solicitation for radiopharmaceuticals. The solicitation is being conducted by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 on behalf of the South Texas VA Medical Center in San Antonio, Texas. Vendors are asked to provide unit pricing for 68 different radiopharmaceutical products and services in the highlighted areas of the spreadsheet for the base year and four option years. Quotes must be submitted via email to the Contracting Officer by February 13, 2023 at 5PM CST. It is anticipated this will result in a single award IDIQ to a nuclear pharmacy that can provide products in a timely manner.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| S02 Solicitation 36C25723Q0254.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| Vendors fill out highlighted areas | ||||||||||||
| Pricing Spreadsheet | Vendors are encouraged to list any additional or alternate items they can provide, including new to market products and radiotracers that may provide a contingency source for other Nuclear Medicine Service modalities. | |||||||||||
| South Texas Radio Pharmaceutical 5 Year IDIQ | ||||||||||||
| RFQ: 36C25723Q0254 | ||||||||||||
| Quote Due: 02/13/2023 COB | ||||||||||||
| Vendor: | ||||||||||||
| Unique Entity ID: | ||||||||||||
| Date of Offer: | ||||||||||||
| Quoted Price | Quoted Price | Quoted Price | Quoted Price | Quoted Price | ||||||||
| Item | Product Description | Estimated Quantity | Base Year 03/18/2023 - 03/17/2024 | Base Year Extended Price | OY 1 03/18/2024 - 03/17/2025 | OY 1 Extended Price | OY 2 03/18/2025 - 03/17/2026 | OY 2 Extended Price | OY 3 03/18/2026 - 03/17/2027 | OY 3 Extended Price | OY 4 03/18/2027 - 03/17/2028 | OY 4 Extended Price |
| 1 | Ga-67 Gallium Citrate UD | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 2 | I-123 Iobenguane Sulfate UD | 8 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 3 | I-123 USP NaI 100 uCi Cap | 50 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 4 | I-123 USP NaI 200 uCi Cap | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 5 | I-123 RC NaI Cap | 32 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 6 | I-131 USP NaI DX Cap UD mCi | 30 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 7 | I-131 USP NaI DX Cap UD uCi | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 8 | I-131 USP NaI TX Cap mCi | 1200 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 9 | In-111 Chloride Point Source | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 10 | In-111 Oxyquinoline Point Source | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 11 | In-111 Autologous WBC Suspension UD | 30 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 12 | In-111 Pentetate (UD) SDV/Vial | 10 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 13 | Tc-99m Cardiolite UD | 20 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 14 | Tc-99m Exametazime WBC's UD | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 15 | Tc-99m Filtered Sulfur Colloid UD | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 16 | Tc-99m Filtered Sulfur Colliod (uCi) UD | 8 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 17 | Tc-99m Macro Aggregated Albumin UD | 10 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 18 | Tc-99m MAA Reduced Particle UD | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 19 | Tc-99m Mebrofenin UD | 30 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 20 | Tc-99m Meriatide UD | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 21 | Tc-99m NaTcO4 UD uCi | 50 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 22 | Tc-99m NaTcO4 UD mCi | 20 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 23 | Tc-99m Oxidronate UD | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 24 | Tc-99m Penetate UD | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 25 | Tc-99m Penetate (UD) (Aerosol) | 2 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 26 | Tc-99m Pyrophosphate UD | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 27 | Tc-99m Sestamibi UD | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 28 | Tc-99m Sulfur Colloid UD | 20 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 29 | Tc-99m Tetrofosmin UD | 400 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 30 | Tc-99m Tilmanocept UD syringe | 50 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 31 | Tl-201 Thallous Chloride UD | 30 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 32 | Xe-133 Xenon Gas 20 mCi Vial | 100 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 33 | Xe-133 Xenon Gas 10 mCi Vial | 50 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 34 | Tc-99m Non-HEU Cardiolite (Sestamibi) UD | 40 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 35 | Tc-99m Non-HEU Macro Aggregated Albumin UD | 90 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 36 | Tc-99m Non-HEU MAA Reduced Particle UD | 55 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 37 | Tc-99m Non-HEU Mebrofenin UD | 180 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 38 | Tc-99m Non-HEU Medronate UD | 500 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 39 | Tc-99m Non-HEU Meriatide UD | 30 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 40 | Tc-99m Non-HEU NaTcO4 UD mCi | 180 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 41 | Tc-99m Non-HEU Oxidronate UD | 8 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 42 | Tc-99m Non-HEU Penetate UD | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 43 | Tc-99m Non-Heu Penetate UD (Aerosol) | 8 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 44 | Tc-99m Non-HEU Pyrophosphate UD | 45 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 45 | Tc-99m Non-HEU Sestamibi UD | 30 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 46 | Tc-99m Non-HEU Sulfur Colloid UD | 130 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 47 | Tc-99m Non-HEU Filtered Sulfur Colloid UD | 20 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 48 | Tc-99m Non-HEU Tetrofosmin UD | 3400 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 49 | Tc-99m Non-HEU Autologous WBC's Suspension | 4 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 50 | WBC Blood Kit | 30 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 51 | Ultravent Aerosol Nebulizer | 15 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 52 | Sincalide Solution (UD) - (dose) | 160 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 53 | Ultratag Kits | 110 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 54 | F-18 FDG UD | 850 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 55 | F-18 FDG UD Source | 10 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 56 | F18 NaF UD | 5 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 57 | Ga-68 DOTA-Octreotate Injection UD | 50 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 58 | DC Accuracy | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 59 | DC Geometry | 1 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 60 | DC Linearity | 4 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 61 | After Hours Callout | 60 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 62 | After Hours Delivery Charge | 40 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 63 | Stat | 60 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 64 | Weekday Delivery 3 | 72 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 65 | Weekday Delivery 4 | 72 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 66 | Weekday Delivery 5 | 36 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 67 | Weekend Delivery 3 | 20 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 68 | Tc-99m Medronate UD | 50 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| Total 5 Year Est: | $ - 0 |
File details come from the government source that posted it. Updated .